Skip to content

Facts and Recommendations about Total Homocysteine Determinations: An Expert Opinion

Helga Refsum, A. David Smith, Per Magne Ueland, Ebba Nexø, Robert Clarke, Joseph M McPartlin, Carole Johnston, Frode Engbaek, Jørn Schneede, Catherine McPartlin, John M. Scott

Clinical Chemistry · 2004 · 1,062 citationsOpen access

No retraction on record in OpenAlex.Check Crossref now

Cite this paper

Refsum, H., Smith, A. D., Ueland, P. M., Nexø, E., Clarke, R., McPartlin, J. M., Johnston, C., Engbaek, F., Schneede, J., McPartlin, C., & Scott, J. M. (2004). Facts and recommendations about total homocysteine determinations: An expert opinion. Clinical Chemistry, 50(1), 3–32. https://doi.org/10.1373/clinchem.2003.021634

In text: (Refsum et al., 2004)

Ask a question about this research

One question, free, no account. Anchorcite finds the papers, checks each against Crossref and links every sentence of the answer to the passage it comes from.

Abstract

BACKGROUND: Measurement of plasma total homocysteine has become common as new methods have been introduced. A wide range of disorders are associated with increased concentrations of total homocysteine. The purpose of this review is to provide an international expert opinion on the practical aspects of total homocysteine determinations in clinical practice and in the research setting and on the relevance of total homocysteine measurements as diagnostic or screening tests in several target populations. METHODS: Published data available on Medline were used as the basis for the recommendations. Drafts of the recommendations were critically discussed at meetings over a period of 3 years. OUTCOME: This review is divided into two sections: (a) determination of homocysteine (methods and their performance, sample collection and handling, biological determinants, reference intervals, within-person variability, and methionine loading test); and (b) risk assessment and disease diagnosis (homocystinuria, folate and cobalamin deficiencies, cardiovascular disease, renal failure, psychiatric disorders and cognitive impairment, pregnancy complications and birth defects, and screening of elderly and newborns). Each of these subsections concludes with a separate series of recommendations to assist the clinician and the research scientist in making informed decisions. The review concludes with a list of unresolved questions.

  1. A Quantitative Assessment of Plasma Homocysteine as a Risk Factor for Vascular Disease1995
  2. Tietz Textbook of Clinical Chemistry1999
  3. Homocysteine and Cardiovascular Disease1998
  4. Hyperhomocysteinemia: An Independent Risk Factor for Vascular Disease1991
  5. Homocysteine and Risk of Ischemic Heart Disease and Stroke2002

Metadata from OpenAlex (CC0). Citations are generated from the published record.